Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort

Chronic obstructive pulmonary disease (COPD) is characterized by a slow heterogeneous progression. Therefore, improved biomarkers that can accurately identify patients with the highest likelihood of progression and therefore the ability to benefit from a given treatment, are needed. Elastin is an es...

Descripción completa

Detalles Bibliográficos
Autores principales: Rønnow, Sarah Rank, Langholm, Lasse Løcke, Sand, Jannie Marie Bülow, Thorlacius-Ussing, Jeppe, Leeming, Diana Julie, Manon-Jensen, Tina, Tal-Singer, Ruth, Miller, Bruce E., Karsdal, Morten Asser, Vestbo, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412140/
https://www.ncbi.nlm.nih.gov/pubmed/30858579
http://dx.doi.org/10.1038/s41598-019-40785-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412140/
https://www.ncbi.nlm.nih.gov/pubmed/30858579
http://dx.doi.org/10.1038/s41598-019-40785-2

Ejemplares similares